Company Description
Genzyme and Medtronic are out to prove that it doesn't just take time to heal a broken heart. The two companies' joint venture, MG...
Key MG Biotherapeutics Financials
| Company Type | Joint Venture of Genzyme and Medtronic - Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $4.0 (est.) |
| 2007 Employees | 50 |
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about MG Biotherapeutics's competition across multiple industries
Top MG Biotherapeutics Competitors
Sponsored Links
The Business Directory
MG Biotherapeutics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Co-Collaboration Manager and CFO | Jeffrey Erb | Network | E-mail |
| Co-Collaboration Manager and COO | Fred Chereau | Network | E-mail |
More MG Biotherapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.